| Phosphatidylinositol-specific phospholipase C |
|
Phospholipase Cδ-1
|
| Identifiers |
| Symbol |
PI-PLC-X |
| Pfam |
PF00388 |
| Pfam clan |
CL0384 |
| InterPro |
IPR000909 |
| SMART |
PLCXc |
| PROSITE |
PDOC50007 |
| SCOP |
1gym |
| SUPERFAMILY |
1gym |
| OPM superfamily |
126 |
| OPM protein |
1djx |
| CDD |
cd00137 |
| Available protein structures: |
| Pfam |
structures |
| PDB |
RCSB PDB; PDBe; PDBj |
| PDBsum |
structure summary |
|
| phosphoinositide phospholipase C |
| Identifiers |
| EC number |
3.1.4.11 |
| CAS number |
37213-51-7 |
| Databases |
| IntEnz |
IntEnz view |
| BRENDA |
BRENDA entry |
| ExPASy |
NiceZyme view |
| KEGG |
KEGG entry |
| MetaCyc |
metabolic pathway |
| PRIAM |
profile |
| PDB structures |
RCSB PDB PDBe PDBsum |
| Gene Ontology |
AmiGO / EGO |
| Search |
| PMC |
articles |
| PubMed |
articles |
| NCBI |
proteins |
|
|
|
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (July 2011) (Learn how and when to remove this template message) |
Phosphoinositide phospholipase C (PLC) (EC 3.1.4.11, triphosphoinositide phosphodiesterase, phosphoinositidase C, 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase, monophosphatidylinositol phosphodiesterase, phosphatidylinositol phospholipase C, PI-PLC, 1-phosphatidyl-D-myo-inositol-4,5-bisphosphate inositoltrisphosphohydrolase) is a family of eukaryotic intracellular enzymes that play an important role in signal transduction processes.[1] These enzymes belong to a larger superfamily of Phospholipase C. Other families of phospholipase C enzymes have been identified in bacteria and trypanosomes. Phospholipases C are phosphodiesterases.
Phospholipase Cs participate in phosphatidylinositol 4,5-bisphosphate (PIP2) metabolism and lipid signaling pathways in a calcium-dependent manner. At present, the family consists of six sub-families comprising a total of 13 separate isoforms that differ in their mode of activation, expression levels, catalytic regulation, cellular localization, membrane binding avidity and tissue distribution. All are capable of catalyzing the hydrolysis of PIP2 into two important second messenger molecules, which go on to alter cell responses such as proliferation, differentiation, apoptosis, cytoskeleton remodeling, vesicular trafficking, ion channel conductance, endocrine function and neurotransmission.
Contents
- 1 Reaction and catalytic mechanism
- 2 Cell location
- 3 Function
- 4 Domain structure
- 5 Isozymes and activation
- 5.1 PLC-β
- 5.2 PLC-γ
- 5.3 PLC-δ
- 5.4 Other PLC families
- 6 Human proteins in this family
- 7 References
- 8 See also
Reaction and catalytic mechanism
All family members are capable of catalyzing the hydrolysis of PIP2, a phosphatidylinositol at the inner leaflet of the plasma membrane into the two second messengers, inositol triphosphate (IP3) and diacylglycerol (DAG).
The chemical reaction may be expressed as:
- 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H2O 1D-myo-inositol 1,4,5-trisphosphate + diacylglycerol
Thus, the two substrates of this enzyme are H2O and 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate (PIP2, phosphatidylinositol bisphosphate), whereas its two products are diacylglycerol and 1D-myo-inositol 1,4,5-trisphosphate (IP3, inositol triphosphate).
PLCs catalyze the reaction in two sequential steps. The first reaction is a phosphotransferase step that involves an intramolecular attack between the hydroxyl group at the 2' position on the inositol ring and the adjacent phosphate group resulting in a cyclic IP3 intermediate. At this point, DAG is generated. However, in the second phosphodiesterase step, the cyclic intermediate is held within the active site long enough to be attacked by a molecule of water, resulting in a final acyclic IP3 product. It should be mentioned that bacterial forms of the enzyme, which contain only the catalytic lipase domain, produce cyclic intermediates exclusively, whereas the mammalian isoforms generate predominantly the acyclic product. However, it is possible to alter experimental conditions (e.g., temperature, pH) in vitro such that some mammalian isoforms will alter the degree to which they produce mixtures of cyclic/acyclic products along with DAG.[citation needed] This catalytic process is tightly regulated by reversible phosphorylation of different phosphoinositides and their affinity for different regulatory proteins.[2][3][4]
Cell location
PLCs perform their catalytic function at the plasma membrane where their substrate PIP2 is present. This membrane docking is mediated mostly by lipid-binding domains (e.g. PH domain and C2 domain) that display affinity for different phospholipid components of the plasma membrane. It is important to note that research has also discovered that, in addition to the plasma membrane, PLCs also exist within other sub-cellular regions such as the cytoplasm and nucleus of the cell. At present, it is unclear exactly what the definitive roles for these enzymes in these cellular compartments are, particularly the nucleus.
Function
PIP2 cleavage to IP3 and DAG
Phospholipase C performs a catalytic mechanism, generating inositol triphosphate (IP3) and diacylglycerol (DAG).
These molecules then go on to modulate the activity of downstream proteins important for cellular signaling. IP3 is soluble, and diffuses through the cytoplasm and interacts with IP3 receptors on the endoplasmic reticulum, causing the release of calcium and raising the level of intracellular calcium.
Further reading: Function of calcium in humans
DAG remains tethered to the inner leaflet of the plasma membrane due to its hydrophobic character, where it recruits protein kinase C (PKC), which becomes activated in conjunction with binding calcium ions. This results in a host of cellular responses through stimulation of calcium-sensitive proteins such as Calmodulin.
Further reading: Function of protein kinase C
| PI-PLC-Y |
|
activated rac1 bound to its effector phospholipase c beta 2
|
| Identifiers |
| Symbol |
PI-PLC-Y |
| Pfam |
PF00387 |
| Pfam clan |
CL0384 |
| InterPro |
IPR001711 |
| SMART |
PLCYc |
| PROSITE |
PDOC50007 |
| SCOP |
1qas |
| SUPERFAMILY |
1qas |
| OPM superfamily |
126 |
| OPM protein |
2ptd |
| Available protein structures: |
| Pfam |
structures |
| PDB |
RCSB PDB; PDBe; PDBj |
| PDBsum |
structure summary |
|
Domain structure
In terms of domain organization, all family members possess homologous X and Y catalytic domains in the form of a distorted Triose Phosphate Isomerase (TIM) barrel with a highly disordered, charged, and flexible intervening linker region. Likewise, all isoforms possess four EF hand domains, and a single C2 domain that flank the X and Y catalytic core. An N-terminal PH domain is present in every family except for the sperm-specific ζ isoform.
SH2 (phosphotyrosine binding) and SH3 (proline-rich-binding) domains are found only in the γ form (specifically within the linker region), and only the ε form contains both guanine nucleotide exchange factor (GEF) and RA (Ras Associating) domains. The β subfamily is distinguished from the others by the presence of a long C-terminal extension immediately downstream of the C2 domain, which is required for activation by Gαq subunits, and which plays a role in plasma membrane binding and nuclear localization.
Isozymes and activation
The Phospholipase C family consists of 13 isozymes split between six subfamilies, PLC-δ (1,3 & 4), -β(1-4), -γ(1,2), -ε, -ζ, and the recently discovered -η(1,2) isoform. Depending on the specific subfamily in question, activation can be highly variable. Activation by either Gαq or Gβγ G-protein subunits (making it part of a G protein-coupled receptor signal transduction pathway) or by transmembrane receptors with intrinsic or associated tyrosine kinase activity has been reported. In addition, members of the Ras superfamily of small GTPases (namely the Ras and Rho subfamilies) have also been implicated. It should also be mentioned that all forms of Phospholipase C require calcium for activation, many of them possessing multiple calcium contact sites in the catalytic region. The only isoform that is known to be inactive at basal intracellular calcium levels is the δ subfamily of enzymes suggesting that they function as calcium amplifiers that become activated downstream of other PLC family members.
PLC-β
PLC-β(1-4) (120-155kDa) are activated by Gαq subunits through their C2 domain and long C-terminal extension. Gβγ subunits are known to activate the β2 and β3 isozymes only; however, this occurs through the PH domain and/or through interactions with the catalytic domain. The exact mechanism still requires further investigation. The PH domain of β2 and β3 plays a dual role, much like PLC-δ1, by binding to the plasma membrane, as well as being a site of interaction for the catalytic activator. However, PLC-β binds to the lipid surface independent of PIP2 with all isozymes preferring phosphoinositol-3-phosphate or neutral membranes.
Members of the Rho GTPase family (e.g., Rac1, Rac2, Rac3, and cdc42) have been implicated in their activation by binding to an alternate site on the N-terminal PH domain followed by subsequent recruitment to the plasma membrane. A crystal structure of Rac1 bound to the PH domain of PLCβ2 has been solved. Like PLC-δ1, many PLC-β isoforms (in particular, PLC-β1) have been found to take up residence in the nuclear compartment. A basic amino acid region within the enzyme's long C-terminal tail appears to function as a Nuclear Localization Signal for import into the nucleus. PLC-β1 seems to play unspecified roles in cellular proliferation and differentiation.
PLC-γ
PLC-γ (120-155kDa) is activated by receptor and non-receptor tyrosine kinases due to the presence of two SH2 and a single SH3 domain situated between a split PH domain within the linker region. Although this particular isoform does not contain classic nuclear export or localization sequences, it has been found within the nucleus of certain cell lines.[citation needed] There are two main isoforms of PLCγ expressed in human specimens, PLC-γ1 and PLC-γ2.[5]
PLC-γ2
PLC-γ2 plays a major role in BCR signal transduction. Absence of this enzyme in knockout specimens severely inhibits the development of B cells because the same signaling pathways necessary for antigen mediated B cell activation are necessary for B cell development from CLPs.[5]
In B cell signaling, PI 3-kinase is recruited to the BCR early in the signal transduction pathway. PI-3K phosphorylates PIP2 (Phosphatidylinositol 4,5-bisphosphate) into PIP3 (Phosphatidylinositol 3,4,5-trisphosphate). The increase in concentration of PIP3 recruits PLC-γ2 to the BCR complex which binds to BLNK on the BCR scaffold and membrane PIP3. PLC-γ2 is then phosphorylated by Syk on one site and Btk on two sites. PLC-γ2 then competes with PI-3K for PIP2 which it hydrolyzes into IP3 (inositol 1,4,5-triphosphate), which ultimately raises intercellular calcium, and diacylglycerol (DAG), which activates portions of the PKC family. Because PLC-γ2 competes for PIP2 with the original signaling molecule PI3K, it serves as a negative feedback mechanism.[5]
PLC-δ
The PLC-δ subfamily consists of three family members, δ1, 2, and 3. PLC-δ1 (85kDa) is the most well understood of the three. The enzyme is activated by high calcium levels generated by other PLC family members, and therefore functions as a calcium amplifier within the cell. Binding of its substrate PIP2 to the N-terminal PH domain is highly specific and functions to promote activation of the catalytic core. In addition, this specificity helps tether the enzyme tightly to the plasma membrane in order to access substrate through ionic interactions between the phosphate groups of PIP2 and charged residues in the PH domain. While the catalytic core does possess a weak affinity for PIP2, the C2 domain has been shown to mediate calcium-dependent phospholipid binding as well. In this model, the PH and C2 domains operate in concert as a "tether and fix" apparatus necessary for processive catalysis by the enzyme.
Phospholipase C-delta isoform 1. Blue plane shows hydrocarbon boundary of the lipid bilayer
PLC-δ1 also possesses a classical leucine-rich nuclear export signal (NES) in its EF hand motif, as well as a Nuclear localization signal within its linker region. These two elements combined allow PLC-δ1 to actively translocate into and out of the nucleus. However, its function in the nucleus remains unclear.
The widely expressed PLC-δ1 isoform is the best-characterized phospholipase family member, as it was the first to have high-resolution X-ray crystal structures available for analysis. In terms of domain architecture, all of the enzymes are built upon a common PLC-δ backbone, wherein each family displays similarities, as well as obvious distinctions, that contribute to unique regulatory properties within the cell. Because it is the only family found expressed in lower eukaryotic organisms such as yeast and slime molds, it is considered the prototypical PLC isoform. The other family members more than likely evolved from PLC-δ as their domain architecture and mechanism of activation were expanded. Although a full crystal structure has not been obtained, high-resolution X-ray crystallography has yielded the molecular structure of the N-terminal PH domain complexed with its product IP3, as well as the remainder of the enzyme with the PH domain ablated. These structures have provided researchers with the necessary information to begin speculating about other family members such as PLCβ2.
Other PLC families
- PLC-ε (230-260kDa ) is activated by Ras and Rho GTPases.
- PLC-ζ (75kDa) is thought to play an important role in vertebrate fertilization by producing intracellular calcium oscillations important for the start of embryonic development. However, the mechanism of activation still remains unclear. This isoform is also capable of entering the early-formed pronucleus after fertilization, which seems to coincide with the cessation of calcium mobilization. It, like PLC-δ1 and PLC-β, possesses nuclear export and localization sequences.
- PLC-η has been implicated in neuronal functioning.
Human proteins in this family
PLCB1; PLCB2; PLCB3; PLCB4; PLCD1; PLCD3; PLCD4; PLCE1; PLCG1; PLCG2; PLCH1; PLCH2; PLCL1; PLCL2; PLCZ1
References
- ^ Meldrum E, Parker PJ, Carozzi A (1991). "The PtdIns-PLC superfamily and signal transduction". Biochim. Biophys. Acta. 1092 (1): 49–71. doi:10.1016/0167-4889(91)90177-Y. PMID 1849017.
- ^ Rhee SG, Choi KD (1992). "Multiple forms of phospholipase C isozymes and their activation mechanisms". Adv. Second Messenger Phosphoprotein Res. 26: 35–61. PMID 1419362.
- ^ Rhee SG, Choi KD (1992). "Regulation of inositol phospholipid-specific phospholipase C isozymes". J. Biol. Chem. 267 (18): 12393–12396. PMID 1319994.
- ^ Sternweis PC, Smrcka AV (1992). "Regulation of phospholipase C by G proteins". Trends Biochem. Sci. 17 (12): 502–506. doi:10.1016/0968-0004(92)90340-F. PMID 1335185.
- ^ a b c DeFranco, Anthony (2008). "Chapter 8: B Lymphocyte Signaling Mechanisms and Activation". In Paul, William. Fundamental Immunology (Book) (6th ed.). Philadelphia: Lippincott Williams & Wilkins. pp. 270–288. ISBN 0-7817-6519-6.
- Downes CP, Michell RH (1981). "The polyphosphoinositide phosphodiesterase of erythrocyte membranes". Biochem. J. 198 (1): 133–40. PMC 1163219. PMID 6275838.
- Thompson W; Dawson RMC (1964). "The triphosphoinositide phosphodiesterase of brain tissue". Biochem. J. 91 (2): 237–243. PMC 1202878. PMID 4284484.
- Rhee SG, Bae YS (1997). "Regulation of phosphoinositide-specific phospholipase C isozymes". J. Biol. Chem. 272 (24): 15045–8. doi:10.1074/jbc.272.24.15045. PMID 9182519.
See also
- Phospholipase
- Clostridium perfringens alpha toxin
- Lipid signaling
- Zinc-dependent phospholipase C, a different family of phospholipase C
- PH domain, found in some phospholipases C
- Phospholipase C at the US National Library of Medicine Medical Subject Headings (MeSH)
|
Intracellular signaling peptides and proteins
|
|
| MAP |
|
|
| Calcium |
- Intracellular calcium-sensing proteins
- Calcineurin
- Ca2+/calmodulin-dependent protein kinase
|
|
| G protein |
| Heterotrimeric |
| cAMP: |
- Heterotrimeric G protein
- Adenylate cyclase
- cAMP
- 3',5'-cyclic-AMP phosphodiesterase
- Protein kinase A
|
|
| cGMP: |
- Transducin
- Gustducin
- Guanylate cyclase
- cGMP
- 3',5'-cyclic-GMP phosphodiesterase
- Protein kinase G
|
|
- G alpha subunit Gα
- GNAO1
- GNAI1
- GNAI2
- GNAI3
- GNAT1
- GNAT2
- GNAT3
- GNAZ
- GNAS
- GNAL
- GNAQ
- GNA11
- GNA12
- GNA13
- GNA14
- GNA15/GNA16
|
|
- G beta-gamma complex Gβ
- Gγ
- GNGT1
- GNGT2
- GNG2
- GNG3
- GNG4
- GNG5
- GNG7
- GNG8
- GNG10
- GNG11
- GNG12
- GNG13
- BSCL2
|
|
- G protein-coupled receptor kinase
- AMP-activated protein kinase
|
|
|
| Monomeric |
- ARFs
- Rabs
- Ras
- Rhos
- Arfs
- Ran
- Rhebs
- Raps
- RGKs
|
|
|
| Cyclin |
- Cyclin-dependent kinase inhibitor protein
- Cyclin-dependent kinase
- Cyclin
|
|
| Lipid |
- Phosphoinositide phospholipase C
- Phospholipase C
|
|
| Other protein kinase |
| Serine/threonine: |
- Casein kinase
- eIF-2 kinase
- Glycogen synthase kinase
- GSK1
- GSK2
- GSK-3
- GSK3A
- GSK3B
- IκB kinase
- Interleukin-1 receptor-associated kinase
- Lim kinase
- p21-activated kinases
- Rho-associated protein kinase
- Ribosomal s6 kinase
|
|
| Tyrosine: |
- ZAP70
- Focal adhesion protein-tyrosine kinase
- BTK
|
|
| both |
|
|
|
| Other protein phosphatase |
| Serine/threonine: |
|
|
| Tyrosine: |
- protein tyrosine phosphatase: Receptor-like protein tyrosine phosphatase
- Sh2 domain-containing protein tyrosine phosphatase
|
|
| both: |
- Dual-specificity phosphatase
|
|
|
| Apoptosis |
- see apoptosis signaling pathway
|
|
| GTP-binding protein regulators |
- see GTP-binding protein regulators
|
|
| Other |
- Activating transcription factor 6
- Signal transducing adaptor protein
- I-kappa B protein
- Mucin-4
- Olfactory marker protein
- Phosphatidylethanolamine binding protein
- EDARADD
- PRKCSH
|
|
|
see also deficiencies of intracellular signaling peptides and proteins
|
|
Cell signaling: lipid signaling
|
|
| Extracellular |
| Eicosanoids |
- Classic: Eoxins;
- Leukotrienes (LTR)
- Prostacyclin (IPR)
- Prostaglandins (PGR)
- Thromboxane (TXR)
- Nonclassic: EETs
- Endocannabinoids (CBR)
- Epi-lipoxins (FPR2)
- Hepoxilins
- Isoprostanes
- Lipoxins (FPR2)
- Oxoeicosanoids (OXER)
- Resolvins (FPR2)
|
|
| Lysophospholipids |
|
|
| Steroids |
- Bile acids (GPBAR)
- Neurosteroids
- Pheromones (VNR)
|
|
| Others |
|
|
|
| Intracellular |
|
Nuclear receptor
|
- Steroids: Sex steroids: Androgens (AR)
- Estrogens (ER)
- Progestogens (PR); Corticosteroids: Glucocorticoids (GR)
- Mineralocorticoids (MR); Others: Bile acids (FXR)
- Calcitriol (VDR); Others: Eicosanoids (PPAR)
- Free fatty acids (PPAR)
- Retinoic acid (RAR, RXR)
|
|
|
Second messenger
|
- General: Arachidonic acid
- DAG (PKC, TRPC)
- IP3 (IP3R, RyR)
- Phosphatidic acid
- Phosphoinositides: PIP2 (IRKs)
- PIP3 (PKB/Akt, Btk, PDPK1)
- PtdIns(3,4)P2 (PKB/Akt, PDPK1); Sphingolipids: C1P
- Ceramide (CAPPs, KSR1, PKCζ, CTSD)
- Glucosylceramides
- S1P
- Sphingosine (SDK1, PKH, YPK)
|
|
|
| Precursors |
| General |
|
|
| Steroids |
- Squalene
- Lanosterol
- Cholesterol
|
|
|
Hydrolase: esterases (EC 3.1)
|
|
3.1.1: Carboxylic
ester hydrolases |
- Cholinesterase
- Acetylcholinesterase
- Butyrylcholinesterase
- Pectinesterase
- 6-phosphogluconolactonase
- PAF acetylhydrolase
- Lipase
- Bile salt-dependent
- Gastric/Lingual
- Pancreatic
- Lysosomal
- Hormone-sensitive
- Endothelial
- Hepatic
- Lipoprotein
- Monoacylglycerol
- Diacylglycerol
|
|
| 3.1.2: Thioesterase |
- Palmitoyl protein thioesterase
- Ubiquitin carboxy-terminal hydrolase L1
- 4-hydroxybenzoyl-CoA thioesterase
|
|
| 3.1.3: Phosphatase |
- Alkaline phosphatase
- Acid phosphatase (Prostatic)/Tartrate-resistant acid phosphatase/Purple acid phosphatases
- Nucleotidase
- Glucose 6-phosphatase
- Fructose 1,6-bisphosphatase
- Protein phosphatase
- OCRL
- Pyruvate dehydrogenase phosphatase
- Fructose 6-P,2-kinase:fructose 2,6-bisphosphatase
- PTEN
- Phytase
- Inositol-phosphate phosphatase
- Protein phosphatase: Protein tyrosine phosphatase
- Protein serine/threonine phosphatase
- Dual-specificity phosphatase
|
|
3.1.4:
Phosphodiesterase |
- Autotaxin
- Phospholipase
- Sphingomyelin phosphodiesterase
- PDE1
- PDE2
- PDE3
- PDE4A/PDE4B
- PDE5
- Lecithinase (Clostridium perfringens alpha toxin)
- Cyclic nucleotide phosphodiesterase
|
|
| 3.1.6: Sulfatase |
- arylsulfatase
- Arylsulfatase A
- Arylsulfatase B
- Arylsulfatase E
- Steroid sulfatase
- Galactosamine-6 sulfatase
- Iduronate-2-sulfatase
- N-acetylglucosamine-6-sulfatase
|
|
Nuclease (includes
deoxyribonuclease
and ribonuclease) |
3.1.11-16:
Exonuclease |
| Exodeoxyribonuclease |
|
|
| Exoribonuclease |
|
|
|
3.1.21-31:
Endonuclease |
| Endodeoxyribonuclease |
- Deoxyribonuclease I
- Deoxyribonuclease II
- Deoxyribonuclease IV
- Restriction enzyme
- UvrABC endonuclease
|
|
| Endoribonuclease |
- RNase III
- RNase H
- RNase P
- RNase A
- RNase T1
- RNA-induced silencing complex
|
|
| either deoxy- or ribo- |
- Aspergillus nuclease S1
- Micrococcal nuclease
|
|
|
|
Enzymes
|
|
| Activity |
- Active site
- Binding site
- Catalytic triad
- Oxyanion hole
- Enzyme promiscuity
- Catalytically perfect enzyme
- Coenzyme
- Cofactor
- Enzyme catalysis
|
|
| Regulation |
- Allosteric regulation
- Cooperativity
- Enzyme inhibitor
|
|
| Classification |
- EC number
- Enzyme superfamily
- Enzyme family
- List of enzymes
|
|
| Kinetics |
- Enzyme kinetics
- Eadie–Hofstee diagram
- Hanes–Woolf plot
- Lineweaver–Burk plot
- Michaelis–Menten kinetics
|
|
| Types |
- EC1 Oxidoreductases (list)
- EC2 Transferases (list)
- EC3 Hydrolases (list)
- EC4 Lyases (list)
- EC5 Isomerases (list)
- EC6 Ligases (list)
|
